China Advanced Therapy Medicinal Products Cdmo Market Size & Outlook

Name: China Advanced Therapy Medicinal Products Cdmo Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The advanced therapy medicinal products cdmo market in China is expected to reach a projected revenue of US$ 1,788.6 million by 2030. A compound annual growth rate of 23.9% is expected of China advanced therapy medicinal products cdmo market from 2025 to 2030.

Biotechnology
- Cell Culture & Stem Cell
  - Advanced Therapy Medicinal Products CDMO Market Outlook

China advanced therapy medicinal products cdmo product outlook (Revenue, USD million, 2018-2030)
- Gene Therapy
- Cell Therapy
- Tissue Engineered
- Others (Combined ATMPs, for example biodegradable matric or scaffold)
China advanced therapy medicinal products cdmo phase outlook (Revenue, USD million, 2018-2030)
- Phase I
- Phase II
- Phase III
- Phase IV
China advanced therapy medicinal products cdmo indication outlook (Revenue, USD million, 2018-2030)
- Oncology
- Cardiology
- Central nervous system
- Musculoskeletal
- Infectious disease
- Dermatology
- Endocrine, metabolic, genetic
- Immunology & inflammation
- Opthalmology
- Haematology
- GasteRoNorth Americanterology
- Others

China Advanced Therapy Medicinal Products Cdmo Market Size & Outlook

Data Tree

Sign up - it's easy, and free!